Arcus Biosciences, Inc.
RCUS
Revenue
39.00M
▼-106.00M▼-73.10%
3 Months ChangeAssets
1.19B
▼-107.00M▼-8.28%
3 Months ChangeLiabilities
695.12M
▼-34.27M▼-4.70%
3 Months ChangeFree Cash Flow
-6.00M
▲95.00M▲94.06%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0001724521-24-000153
2024-08-27
Form 8-K
ID: 0001724521-24-000144
2024-08-08
Form 10-Q
ID: 0001724521-24-000138
2024-08-08
Form 8-K
ID: 0001724521-24-000136
2024-06-06
Form 8-K
ID: 0001724521-24-000101
2024-06-03
Form 8-K
ID: 0001724521-24-000099
2024-05-23
Form 8-K
ID: 0001724521-24-000096
2024-05-08
Form 10-Q
ID: 0001724521-24-000092
2024-05-08
Form 8-K
ID: 0001724521-24-000090
2024-02-21
Form 8-K
ID: 0001724521-24-000050